|

Multiple Sclerosis Clinical Trials in Seattle, WA

18 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisPhase 3<1 mi
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyPhase 2<1 mi
Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis FatigueN/A<1 mi
Confirmatory Trial for Alleviating Fatigue in Multiple SclerosisN/A<1 mi
Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple SclerosisPhase 1<1 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Phase 3<1 mi
A Study of AZD0120 in Autoimmune DiseasesPhase 1<1 mi
An Open-label Study of AZD0120 in Adults With Multiple SclerosisPhase 1<1 mi
A Study of LY3541860 in Adult Participants With Relapsing Multiple SclerosisPhase 2<1 mi
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabPhase 3<1 mi
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot StudyN/A<1 mi
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)N/A<1 mi
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Phase 1<1 mi
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisPhase 3<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2<1 mi
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityPhase 28 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—8 mi
Complementary and Alternative Care in Multiple Sclerosis—11 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.